ABVC BioPharma, Inc. (ECOC) Operating margin 2018–2025
ABVC BioPharma, Inc. (ECOC) operating margin by fiscal year — reported operating income divided by reported revenue.
-2416.0%FY2025 · since FY2018: -40031.1% → -2416.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2416.0% | -1492.6 pp |
| FY2024 | -923.3% | +3515.9 pp |
| FY2023 | -4439.2% | -2880.7 pp |
| FY2022 | -1558.5% | +1731.5 pp |
| FY2021 | -3290.1% | -1529.2 pp |
| FY2020 | -1760.9% | -1268.0 pp |
| FY2019 | -492.9% | +39538.2 pp |
| FY2018 | -40031.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ECOC financial trends
ECOC RevenueECOC Net incomeECOC Net marginECOC Gross profitECOC Gross marginECOC Operating incomeECOC Operating cash flowECOC Free cash flowECOC Capital expendituresECOC Return on equityECOC Stock buybacksECOC Dividends paidECOC Total assetsECOC Total liabilitiesECOC Shareholders’ equityECOC overview →